Gajic Ognjen, Gropper Michael A, Hubmayr Rolf D
Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.
Crit Care Med. 2006 May;34(5 Suppl):S109-13. doi: 10.1097/01.CCM.0000214311.56231.23.
Pulmonary edema is an under-recognized and potentially serious complication of blood transfusion. Distinct mechanisms include adverse immune reactions and circulatory overload. The former is associated with increased pulmonary vascular permeability and is commonly referred to as transfusion-related acute lung injury (TRALI). The latter causes hydrostatic pulmonary edema and is commonly referred to as transfusion-associated circulatory overload (TACO). In this review article we searched the National Library of Medicine PubMed database as well as references of retrieved articles and summarized the methods for differentiating between hydrostatic and permeability pulmonary edema.
The clinical and radiologic manifestations of TACO and TRALI are similar. Although echocardiography and B-type natriuretic peptide measurements may aid in the differential diagnosis between hydrostatic and permeability pulmonary edema, invasive techniques such as right heart catheterization and the sampling of alveolar fluid protein are sometimes necessary. The diagnostic differentiation is especially difficult in critically ill patients will multiple comorbidities so that the cause of edema may only be determined post hoc based on the clinical course and response to therapy. Guided by available evidence, we present an algorithm for establishing the pretest probability of TRALI as opposed to TACO. The decision to test donor and recipient blood for immunocompatibility may be made on this basis.
The distinction between hydrostatic (TACO) and permeability (TRALI) pulmonary edema after transfusion is difficult, in part because the two conditions may coexist. Knowledge of strengths and limitations of different diagnostic techniques is necessary before initiation of complex TRALI workup.
肺水肿是输血未被充分认识且可能严重的并发症。不同机制包括不良免疫反应和循环超负荷。前者与肺血管通透性增加有关,通常称为输血相关急性肺损伤(TRALI)。后者导致静水压性肺水肿,通常称为输血相关循环超负荷(TACO)。在这篇综述文章中,我们检索了美国国立医学图书馆的PubMed数据库以及检索到的文章的参考文献,并总结了区分静水压性肺水肿和通透性肺水肿的方法。
TACO和TRALI的临床和影像学表现相似。虽然超声心动图和B型利钠肽测量可能有助于静水压性肺水肿和通透性肺水肿的鉴别诊断,但有时需要右心导管检查和肺泡液蛋白采样等侵入性技术。在患有多种合并症的重症患者中,诊断鉴别尤其困难,因此水肿原因可能只能在事后根据临床病程和对治疗的反应来确定。根据现有证据,我们提出了一种算法,用于确定TRALI与TACO的验前概率。可在此基础上决定检测供体和受者血液的免疫相容性。
输血后静水压性(TACO)和通透性(TRALI)肺水肿的区分很困难,部分原因是这两种情况可能同时存在。在开始复杂的TRALI检查之前,了解不同诊断技术的优缺点是必要的。